Natco Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has submitted a compliance disclosure to the stock exchange under Regulation 31(4) of SEBI's Takeover Regulations, 2011. This regulation requires promoters and persons in control of a listed company to disclose details of any encumbrance (such as pledges or liens) on their shares, typically filed annually. The filing itself is a routine regulatory submission and the actual content of the disclosure — including any details on pledged shares by promoters — is not included in the headline. Investors should look at the attached disclosure document for the specific numbers on promoter shareholding and any encumbrances.
This is a routine compliance filing and on its own is unlikely to move the stock. Shareholders should check the actual disclosure to confirm whether any promoter shares are pledged, as high pledging levels can be a concern.